195 related articles for article (PubMed ID: 37124437)
1. Beta-Blockers in the Prevention and Treatment of Ischemic Heart Disease: Evidence and Clinical Practice.
Khan O; Patel M; Tomdio AN; Beall J; Jovin IS
Heart Views; 2023; 24(1):41-49. PubMed ID: 37124437
[TBL] [Abstract][Full Text] [Related]
2. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
3. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of β-blocker therapy for secondary prevention for patients undergoing coronary artery bypass grafting surgery.
Sun C; Zhang H; Zheng Z
Curr Opin Cardiol; 2016 Nov; 31(6):654-661. PubMed ID: 27748695
[TBL] [Abstract][Full Text] [Related]
5. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
Ellison KE; Gandhi G
Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.
Kones R
Vasc Health Risk Manag; 2010 Sep; 6():749-74. PubMed ID: 20859545
[TBL] [Abstract][Full Text] [Related]
7. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
[TBL] [Abstract][Full Text] [Related]
8. Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease.
Godoy LC; Farkouh ME; Austin PC; Shah BR; Qiu F; Jackevicius CA; Wijeysundera HC; Krumholz HM; Ko DT
J Am Coll Cardiol; 2023 Jun; 81(24):2299-2311. PubMed ID: 37316110
[TBL] [Abstract][Full Text] [Related]
9. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
10. Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
Fukase T; Dohi T; Koike T; Yasuda H; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
ESC Heart Fail; 2022 Feb; 9(1):545-554. PubMed ID: 34811932
[TBL] [Abstract][Full Text] [Related]
11. Prevention of acute coronary events in noncardiac surgery: beta-blocker therapy and coronary revascularization.
Flu WJ; van Kuijk JP; Winkel T; Hoeks S; Bax J; Poldermans D
Expert Rev Cardiovasc Ther; 2009 May; 7(5):521-32. PubMed ID: 19419260
[TBL] [Abstract][Full Text] [Related]
12. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
[TBL] [Abstract][Full Text] [Related]
13. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery.
Bauer SM; Cayne NS; Veith FJ
J Vasc Surg; 2010 Jan; 51(1):242-51. PubMed ID: 19954922
[TBL] [Abstract][Full Text] [Related]
14. Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?
Bacaner M; Brietenbucher J; LaBree J
Am J Ther; 2004; 11(5):366-411. PubMed ID: 15356432
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
16. Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
Chung J; Han JK; Kim YJ; Kim CJ; Ahn Y; Chan Cho M; Chae SC; Chae IH; Chae JK; Seong IW; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066446
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
[TBL] [Abstract][Full Text] [Related]
18. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(8):1-64. PubMed ID: 23074411
[TBL] [Abstract][Full Text] [Related]
19. Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis.
Bertrand ME; Ferrari R; Remme WJ; Simoons ML; Fox KM
Am Heart J; 2015 Dec; 170(6):1092-8. PubMed ID: 26678630
[TBL] [Abstract][Full Text] [Related]
20. β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.
Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tazaki J; Natsuaki M; Kimura T;
Int J Cardiol; 2013 Sep; 168(2):774-9. PubMed ID: 23127614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]